Breast Implant Patient Preferences Topic Of New FDA Study
The US agency’s study will look at how the potential cancer risk tied to textured breast implants, as well as other factors, play into how patients decide what type of implants to get.
You may also be interested in...
The US FDA has learned of new cancer risks associated with breast implants that differ from cancers the agency has warned about in the past.
The US FDA reports the numbers on women globally who've died or been sickened by two types of breast implant illnesses.
A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.